相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
Silvia Catuogno et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy
Nianxi Zhao et al.
SMALL (2018)
Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care
Christopher M. Hartshorn et al.
ACS NANO (2018)
Rational design of protamine nanocapsules as antigen delivery carriers
Jose Vicente Gonzalez-Aramundiz et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Cancer Nanomedicine: Lessons for Immuno-Oncology
Shiladitya Sengupta
TRENDS IN CANCER (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Aptamers: versatile molecular recognition probes for cancer detection
Hongguang Sun et al.
ANALYST (2016)
Emerging nanotechnologies for cancer immunotherapy
Sourabh Shukla et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2016)
Aptamers and Their Applications in Nanomedicine
Hongguang Sun et al.
SMALL (2015)
Superior Performance of Aptamer in Tumor Penetration over Antibody: Implication of Aptamer-Based Theranostics in Solid Tumors
Dongxi Xiang et al.
THERANOSTICS (2015)
Protamine nanoparticles for improving shRNA-mediated anti-cancer effects
Ming Liu et al.
NANOSCALE RESEARCH LETTERS (2015)
Aptamer-targeted inhibition of mTOR in T cells enhances antitumor immunity
Alexey Berezhnoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
Zihua Zeng et al.
THERANOSTICS (2014)
Anaplastic Large Cell Lymphoma in Children and Adolescents
Eric J. Lowe et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2013)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma
Nianxi Zhao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2011)
Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126
M. Ito et al.
CANCER GENE THERAPY (2010)
Using oligonucleotide aptamer probes for immunostaining of formalin-fixed and paraffin-embedded tissues
Zihua Zeng et al.
MODERN PATHOLOGY (2010)
Development of DNA aptamers using Cell-SELEX
Kwame Sefah et al.
NATURE PROTOCOLS (2010)
Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas.
Anas Younes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Using an RNA aptamer probe for flow cytometry detection of CD30-expressing lymphoma cells
Peng Zhang et al.
LABORATORY INVESTIGATION (2009)
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
Sook Ryun Park et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2006)
Childhood anaplastic large cell lymphoma has a high incidence of ALK gene rearrangement as determined by immunohistochemical staining and fluorescent in situ hybridisation:: a genetic and pathological correlation
SL Perkins et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect
J Weyermann et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization
D Lochmann et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2005)
Comparison of antisense oligonucleotide drug delivery systems
J Weyermann et al.
JOURNAL OF CONTROLLED RELEASE (2004)
RNA aptamers selected against the receptor activator of NF-kappa B acquire general affinity to proteins of the tumor necrosis factor receptor family
T Mori et al.
NUCLEIC ACIDS RESEARCH (2004)
Practicability and acute haematological toxicity of 2-and 3-weekly CHOP and CHOEP chemotherapy for aggressive non-Hodgkin's lymphoma: results from the NHL-B trial of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
A Wunderlich et al.
ANNALS OF ONCOLOGY (2003)
Design and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL)
U Ritter et al.
OLIGONUCLEOTIDES (2003)
Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505
K Itoh et al.
ANNALS OF ONCOLOGY (2002)
Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens
DM Williams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
分享论文
